| Trial Name | Title | Status |
| Acuity | Longitudinal Surveillance Registry (LSR) of ACUITY Spiral | Enrolling |
| CAP 2 | Continued Access to PREVAIL (CAP2)- WATCHMAN Left Atrial Appendage (LAA) Closure Technology | Enrolling |
| INGEVITY | INGEVITY(TM) Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study | Enrolling |
| MultiSENSE | Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients | Enrolling |
| RAID | Ranolazine Implantable Cardioverter-Defibrillator Trial (RAID). Late Sodium Current Blockade in High-Risk ICD Patients | Enrolling |
| Surveillance | Medtronic Product Surveillance Registry | Enrolling |
| Advisa | The purpose of the Advisa MRI™ System clinical study is to confirm safety and effectiveness in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans up to 2W/kg Specific Absorption Rate (SAR) without positioning restrictions (MRI scans may occur anywhere on the body including the chest). | Follow up only |
| PainFree SST | The PainFree SST (SmartShock Technology) Clinical Study is a prospective, multicenter clinical trial with two consecutive phases; “Phase I (Protecta Clinical Study)” followed by “Phase II (PainFree SST Clinical Study)”. Collectively Phase I and Phase II will provide data to support market release of the Protecta devices and evaluate the SmartShock technology features in reducing inappropriate shock. | Follow up only |
| PPP (SLS) | Product Performance Platform - The purpose of post-market surveillance is to "enhance the public health by reducing the incidence of medical device adverse experiences." | Follow up only |
| Prevail | Prospective Randomized EVAluation of Warfarin Therapy In Atrial Fibrillation Patients Versus WATCHMAN LAA Closure Technology (PREVAIL) | Follow up only |